Atlas Trials

A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer

Clinical trial NCT02681237 · COMPLETED

Trial details

NCT number
NCT02681237
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2016-04-29
Primary completion
2022-01-10
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.